Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-22Clinical Trial Update: Zolpidem CR and Hospitalized Patients With Dementia [NA]
A completed clinical trial evaluated zolpidem CR in hospitalized patients with dementia; results were posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Rosiglitazone (Extended Release Tablets) As Monotherapy In Subjects With Mild To Moderate Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating rosiglitazone extended-release as monotherapy in mild-to-moderate Alzheimer's disease has completed with results po…
-
CLINICAL_TRIALS research · 2017-05-16Clinical Trial Update: Effect of Electroacupuncture Combined With Donepezil for Treating Alzheimer's Disease [Phase 2]
A Phase 2 clinical trial evaluates whether electroacupuncture combined with donepezil improves outcomes in Alzheimer's disease; the current …
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: A Based on PEEG and PET Study of Anxiolytic Treatment to Improve Cognitive Function in Patients With Alzheimer Disease [Phase 4]
A Phase 4 clinical trial update describes an anxiolytic treatment being studied for improving cognitive function in Alzheimer's disease, wit…
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Neuro Imaging and Multimodal Alzheimer's Disease [NA]
Clinical trial update reporting a completed study on neuroimaging and multimodal approaches for Alzheimer's disease conducted with sponsor U…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Bupropion for the Treatment of Apathy in Alzheimer's Dementia [Phase 3]
A Phase 3 clinical trial evaluating bupropion for treating apathy in Alzheimer's dementia has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Effects of Triglycerides on Age-Related Cognitive Function Decline in Older Subjects [Phase 1]
A Phase 1 clinical trial sponsored by GlaxoSmithKline examined whether triglyceride levels influence age-related cognitive function decline …
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Computational Tools for Early Diagnosis of Memory Disorders
The trial update reports completion of a University of Eastern Finland–led study evaluating computational tools for early diagnosis of memor…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Down Syndrome Biomarker Initiative (DSBI)
The Down Syndrome Biomarker Initiative (DSBI) trial has completed, documenting biomarker findings in individuals with Down syndrome and Alzh…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Discontinuation of Cholinesterase Inhibitors for the Treatment of Severe Alzheimer's Disease [Phase 3]
Phase 3 clinical trial evaluating discontinuation of cholinesterase inhibitors in severe Alzheimer's disease has completed. The update repor…
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Study to Evaluate Coconut Oil for Alzheimer's Disease [Phase 2, Phase 3]
This update reports the termination of a Phase 2/Phase 3 clinical trial evaluating coconut oil for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-04-28Clinical Trial Update: Apathy Associated With Alzheimer's Disease [Phase 4]
This clinical trial update notes a Phase 4 study investigating apathy in individuals with Alzheimer's disease, which has completed. The snip…
-
CLINICAL_TRIALS trial_result · 2017-04-26Clinical Trial Update: Alzheimers Disease and Neuromarkers in Patients With Acute Hip Fractures
Clinical Trial Update on a completed study investigating neuromarkers in Alzheimer's disease patients with acute hip fractures. The snippet …
-
CLINICAL_TRIALS trial_result · 2017-04-19Clinical Trial Update: Optimisation of Antipsychotic Drug Use in Older People [Phase 4]
Phase 4 clinical trial update on optimizing antipsychotic use in older people with Alzheimer's disease or schizophrenia; the study has been …
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Repeated Subcutaneous Administration of ABvac40 in Mild to Moderate Alzheimer's Disease Patients [Phase 1]
The update indicates completion of a Phase 1 trial evaluating repeated subcutaneous administration of ABvac40 in patients with mild to moder…
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: Volunteers Adding Life in Dementia [NA]
The clinical trial NCT01646723 focusing on dementia and Alzheimer disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-14Clinical Trial Update: The Primary Care - Dementia Assessment and Treatment Algorithm [NA]
The Primary Care - Dementia Assessment and Treatment Algorithm study (NCT01548053) has completed. This summary notes the status but provides…
-
CLINICAL_TRIALS research · 2017-04-14Clinical Trial Update: Can the Assessment of the Subhippocampal Region Contribute to the Detection of Early Diagnosis of Alzheimer's Disease? A Validation Study Using PET With Florbetapir (AV-45). [NA]
A validation study evaluating whether assessing the subhippocampal region with florbetapir PET can contribute to early detection of Alzheime…
-
CLINICAL_TRIALS research · 2017-04-14Clinical Trial Update: Volunteers Adding Life in Dementia: VALID [NA]
This clinical trial update reports that the VALID study (NCT01715181) led by Queen's University has completed, focusing on dementia and Alzh…
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Study to Evaluate the Efficacy and Safety of GSK239512 in Alzheimer's Disease [Phase 2]
A Phase 2 study evaluating GSK239512 for Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2017-04-13Clinical Trial Update: Lipoic Acid and Omega-3 Fatty Acids for Alzheimer's Disease [Phase 1, Phase 2]
A clinical trial update reports completed Phase 1 and Phase 2 studies evaluating alpha-lipoic acid and omega-3 fatty acids for Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Type 2 Diabetes Mellitus as Catalyst for Alzheimer's Disease
A completed clinical trial assessing whether Type 2 diabetes mellitus acts as a catalyst for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2017-04-12Clinical Trial Update: Retinal Neurodegeneration in Type 2 Diabetes as Biomarker for Alzheimer´s Disease
The study explored retinal neurodegeneration in type 2 diabetes as a potential biomarker for Alzheimer's disease. The trial status is comple…
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Depression in Alzheimer's Disease-2 [Phase 2, Phase 3]
The Depression in Alzheimer's Disease-2 trial, covering Phase 2 and Phase 3, has completed with results posted in 2017.
-
CLINICAL_TRIALS trial_result · 2017-04-11Clinical Trial Update: Hearing Instruments in Alzheimer's Disease
A completed clinical trial from Phonak AG evaluating hearing instruments in individuals with Alzheimer's disease and hearing loss.